Prospective Liver Study
This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Hyun Kevin Kim, Emory University
First received: February 15, 2012
Last updated: September 10, 2013
Last verified: September 2013
This study is designed for patients diagnosed with Liver cancer to collect information about the relationship between types of liver cancer, methods of treatment and outcomes over time.
|Study Design:||Time Perspective: Prospective|
|Official Title:||Prospective Analysis of Liver Cancer Treatment and Interventions|
Resource links provided by NLM:
U.S. FDA Resources
Further study details as provided by Emory University:
Primary Outcome Measures:
- Assess efficacy of percutaneous and transarterial treatments for liver cancer. [ Time Frame: 1 month ] [ Designated as safety issue: No ]QOL questionnaire will be collected during follow up visit.
Secondary Outcome Measures:
- long term follow up [ Time Frame: 3 months, 6 months 1year ] [ Designated as safety issue: No ]Patients will be administered QOL during 3 months, 6 months and 1 year follow up.
|Study Start Date:||November 2008|
|Estimated Study Completion Date:||November 2014|
|Estimated Primary Completion Date:||September 2013 (Final data collection date for primary outcome measure)|
Contacts and Locations